Li Xu

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

Ahmed O. Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 256 citations · Full text

Pharmacy, Oncology, Perioperative Medicine +15

Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma

Tina Cascone, Matthew H. Herynk, Li Xu et al. · Journal of Clinical Investigation · 2011 · 162 citations · Full text

Medicine, Oncology, Pharmacology +17

A genome-wide association study yields five novel thyroid cancer risk loci

Jon K. Sigurdsson, Lilja Stefánsdóttir, Jón G. Jónasson et al. · Nature Communications · 2017 · 155 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry

Nan Li, Li Xu, Hui Zhao et al. · Cancer · 2011 · 142 citations · Full text

Medicine, Oncology, Otolaryngology +10

GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer

Wei Zhou, Ben Brumpton, Ömer Kabil et al. · Nature Communications · 2020 · 141 citations · Full text

Medicine, Endocrinology, Genetics +17